Anatrace公司產(chǎn)品訂購，請聯(lián)系蘇州螞蟻淘生物科技有限公司

自上世紀80年代末以來，的研究機構、學術機構和工業(yè)客戶一直信任Anatrace，相信它能提供高純度的洗滌劑、油脂、海關，當然還有更高的標準。由于世邦魏理仕的私募股權投資，世邦魏理仕再次成為一家私營企業(yè)，我們現(xiàn)在將這些標準設定得比以往任何時候都要高。

作為膜蛋白結構生物學領域的佼jiao者，阿納托瑞斯的產(chǎn)品因其*的純分子和其背后的嚴格的化學原理而備受青睞。從設計用來破壞細胞膜的化合物到穩(wěn)定或溶解不穩(wěn)定大分子和蛋白質(zhì)的產(chǎn)品，我們一直在提高標準。因此，你的結構研究，功能生物學工作，或化學合成項目將產(chǎn)生令人難以置信的可靠結果。這就是為什么在過去的5年里，出版物平均每年引用我們400多次。

隨著我們大量的產(chǎn)品組合，我們的化學家可以開發(fā)專門的解決方案，以滿足您*的規(guī)格。我們還可以提供定制的綜合服務和專家分析工作，以幫助您自己的研究和開發(fā)團隊。可能性是無限的——就像我們追求的*一樣。

Anatrace公司產(chǎn)品訂購

MCSG Crystallization Suite

Developed at the Midwest Center for Structural Genomics as part of the Protein Structure Initiative - Most product crystallization conditions

MCSG: MCSG Suite

PRODUCT DESCRIPTIONTECHNICAL DOCUMENTATIONREQUIRED / RELATED PRODUCTS

Storage Conditions: 4-20 C
pH: Varies
Conductance: Varies
Appearance: Clear Solutions

FEATURES

• 384 Crystallization conditions, optimized  through high throughput validation
• Derived from trials of more than 40,000 diverse proteins at the Midwest Center for Structural Genomics
• Broad coverage of crystallization space
• Derived from crystallization of from both prokaryotic and eukaryotic organisms

The MCSG Suite has been developed at the Midwest Center for Structural Genomics. As part of the Protein Structure Initiative, MCSG has been instrumental in the development of rapid, integrated and cost-effective methods for protein structure determination via X-ray crystallography. 

Through extensive crystallization screening of more than 40,000 diverse proteins from both prokaryotic and eukaryotic organisms, researchers at the MCSG have derived the most up-to-date set of crystallization conditions for initial screening. These non-redundant conditions constitute the broadest coverage of crystallization space of any commercially available screen and are supported by a decade of experimental analysis and validation.

The complete MCSG suite (384 conditions) comprises of 4 screens of 96 unique conditions that are available either as deep-well blocks (1.7 mL per well) or tubes (10 ml).  Conditions 1-288 are organized in order of decreasing crystal productivity in screens MCSG-1, MCSG-2 and MCSG-3.  Thus MCSG-1:A1 condition has yielded the greatest number of unique crystals for all targets screened with the suite predecessors.  The conditions that comprise MCSG-4 have been rationally selected to systematically sample regions of crystallization space for proteins requiring additional screening.

The end result is the best, first-pass screening suite possible, with:

• Data-driven selection individual conditions ensuring conditions with high productivity potential were not accidentally excluded
• Superior organization
• The broadest coverage of crystallization space within a reasonable number of starting conditions for maximal efficiency while maintaining applicability for more unique and difficult targets.